Global Pneumonia Diagnostics & Technologies Market

The Pneumonia Diagnostics & Technologies Market size was valued at USD 4.06 Billion in 2025 and the total Pneumonia Diagnostics & Technologies revenue is expected to grow at a CAGR of 8.2% from 2025 to 2032, reaching nearly USD 7.05 Billion by 2032.

The Pneumonia Diagnostics & Technologies Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The Pneumonia Diagnostics & Technologies Market report also provides trends by market segments, technology, and investment with a competitive landscape.

To know about the Research Methodology :- Request Free Sample Report

Pneumonia Diagnostics & Technologies Market Overview:

Pneumonia is an infection in one or both lungs caused by bacteria, viruses, and fungi. The contamination causes inflammation in the air sacs present in the lungs, known as alveoli. The alveoli get filled with fluid or pus and make it difficult for the lungs to breathe. The infection can be life-threatening to any individual if not treated early, most probably in infants, children, and people over 65. Pneumonia symptoms include a cough with phlegm or pus, fever, chills, and difficulty breathing.

Pneumonia Diagnostics & Technologies Market Dynamics:

Pneumonia diagnostics and technologies are estimated to grow in the future due to the rising population and occurrence of diseases in elderly people and developing advanced technologies in pneumonia diagnostics and high incidence of pneumonia among children as well. Pneumonia causes more childhood deaths as compared to AIDS, malaria, and tuberculosis combined. Nearly all infantile pneumonia deaths are avoidable through proper diagnosis and treatment. As the development in the healthcare sector is boosting more treatments and drugs are innovated to offer prevention from diseases.

Recent diagnostic innovations are concurring the market are automated respiratory rate counters together with variation in technologies such as accelerometers, small motion amplification programs, and bioimpedance are some of them, tracheal and chest auscultation with digital processing and examination of respiratory sounds, and host response biomarkers like inflammatory biomarkers like C-reactive protein and procalcitonin, and cardiovascular biomarkers like arginine vasopressin and natriuretic peptides, and exhaled biomarkers like volatile organic compounds. Moreover, the combination of diagnostic and prognostic treatment with recent innovations are estimated to improve the identification of pneumonia and its severity.

Pneumonia Diagnostics & Technologies Market Segment Analysis:

By Product Type, Streptococcus-based, Legionella-based, Chlamydophila based, Viral Pneumonia-based, Mycoplasma Pneumonia-based. The segment Streptococcus-based is dominating the pneumonia diagnosis and technologies market in the forecast period. The streptococcus-based product type was estimate to be the largest in the pneumonia diagnostics market at the end of 2025. Streptococcus pneumonia is spread from one to another by airborne contamination or direct exposure to the bacteria droplets via coughing or sneezing from an infected person. The streptococcus-based segment was valued at more than USD 107 million in 2017. Streptococcus-based pneumonia is considered an aggressive form of infection with an incidence of 10 to 100 cases per population of 100,000 globally.

The viral pneumonia-based segment is estimated to bag the highest CAGR in the pneumonia diagnostics market. The viral pneumonia segment of the pneumonia diagnostics market is estimated to reach USD 182 million in the forecast period making. Viral-based pneumonia is alleged to cause approximately 8% of all cases of community-acquired pneumonia in the cases where patients required hospitalization for the treatment.

Pneumonia Diagnostics & Technologies Market Regional Insights:

Pneumonia Diagnostics & Technologies Market Regional Insights is segmented into North America, Asia Pacific, Latin America, Europe, Middle East, and Africa.

North America has the maximum share in the pneumonia diagnostics market and is dominating the regional segment of the pneumonia diagnostics and technology market. The North America pneumonia diagnostics market is anticipated to USD 201.2 million by the end of the forecast period. The US is dominating the country in North America due to world-class healthcare infrastructure and elderly population more liable to pneumonia and has grabbed larger opportunities than Canada in the North America pneumonia diagnostics market. High awareness about pneumonia and its devastating effects on infants and the elderly are further boosting the demand for pneumonia treatment in the region.

In Europe, the Western Europe pneumonia diagnostics market is estimated to grow with a strong CAGR of 6.4% in the forecast period 2025-2032, making it a region more beneficial in the treatment of the global pneumonia diagnostics market. Moreover, Germany is concurring more attraction as compared to the UK.

The objective of the report is to present a comprehensive analysis of the global Pneumonia Diagnostics & Technologies Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report helps in understanding the global Pneumonia Diagnostics & Technologies Market dynamics, structure by analyzing the market segments and project the global Pneumonia Diagnostics & Technologies Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the global Pneumonia Diagnostics & Technologies Market make the report investor’s guide.

Pneumonia Diagnostics & Technologies Market Scope: Inquire before buying

Pneumonia Diagnostics & Technologies Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Pneumonia Diagnostics & Technologies Market, Key Players

1. Becton Dickinson
2. Affymetrix
3. Bio-Rad
4. Abbott Laboratories
5. Roche
6. Thermo Fisher Scientific
7. bioMeriux
8. DiaSorin and Novartis Diagnostics
9. Directigen S. pneumonia test kit by Becton Dickinson
10.LCx Chlamydia pneumonia
11.Abbott Laboratories
12.Enzo Biochem
13.Fujirebio
14.Grifols
15.GSK Biologicals
16.Hologic
17.Leica Biosystems
18.Lonza
19.Ortho-Clinical Diagnostics

Frequently Asked Questions:

1. Which region has the largest share in Global Pneumonia Diagnostics & Technologies Market?
Ans: North America region held the highest share in 2025.

2. What is the growth rate of Global Market?
Ans: The Global Market is growing at a CAGR of 8.2% during forecasting period 2026-2032.

3. What is scope of the Global Market report?
Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Pneumonia Diagnostics & Technologies Market?
Ans:The important key players in the Global Pneumonia DiagnosticsTechnologies Market are Becton Dickinson,Affymetrix,Bio-Rad,Abbott Laboratories,Roche,Thermo Fisher Scientific,bioMeriux,DiaSorin and Novartis Diagnostics,Directigen S. pneumonia test kit by Becton Dickinson,LCx Chlamydia pneumonia,Abbott Laboratories,Enzo Biochem,Fujirebio,Grifols,GSK Biologicals,Hologic,Leica Biosystems,Lonza,Ortho-Clinical Diagnostics.

5. What is the study period of this Market?
Ans: The Global Pneumonia Diagnostics & Technologies Market is studied from 2025 to 2032.